Sidereal Therapeutics
PrivateLast Round
Grant
May 7, 2025
Total Funding Raised
$400,000
Company Overview
Sidereal Therapeutics is a biotechnology company developing precision biologics to prevent acute kidney injury and treat iron-mediated disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sidereal Therapeutics Comparables
Compare Sidereal Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Renibus Therapeutics | 83% | |
| Arch Biopartners Inc. | 78% | |
| AM-Pharma | 77% |
Sidereal Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 7, 2025 | ||||
| Grant | Dec 22, 2022 |
Sidereal Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New York City Economic Development Corporation | Grant |
| Deerfield Management | Grant |
| Massachusetts Life Sciences Center | Grant |
| Cure by Deerfield | Grant |
| Mission BioCapital | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 22, 2022
$150K grant from Mission BioCapital and MLSC.
Sidereal Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Sidereal Therapeutics's valuation, stock price, and market status.
Is Sidereal Therapeutics a public or private company?
Sidereal Therapeutics is a private company.
What is the current stock price of Sidereal Therapeutics?
Sidereal Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Sidereal Therapeutics worth (valuation)?
Valuation information for Sidereal Therapeutics is not publicly available.
Can I buy Sidereal Therapeutics stock?
Sidereal Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Sidereal Therapeutics's last funding round?
Sidereal Therapeutics's most recent funding round was Grant on May 7, 2025.
Who are the main investors in Sidereal Therapeutics?
Key investors in Sidereal Therapeutics include New York City Economic Development Corporation, Deerfield Management, Massachusetts Life Sciences Center, Cure by Deerfield, Mission BioCapital.
Will Sidereal Therapeutics IPO soon?
No public IPO plans have been announced for Sidereal Therapeutics.
How can I track Sidereal Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sidereal Therapeutics's secondary market activity and sign up for updates.